Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126655652 | 12665565 | 2 | F | 20160921 | 20160818 | 20160926 | PER | US-GLAXOSMITHKLINE-US2016112293 | GLAXOSMITHKLINE | 0.00 | F | Y | 0.00000 | 20160926 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126655652 | 12665565 | 1 | PS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | UNK UNK, U | Y | UNKNOWN | 21077 | INHALATION POWDER | ||||||||
| 126655652 | 12665565 | 2 | SS | SEREVENT DISKUS | SALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 1 PUFF(S), PRN | Y | 6ZP3530 | 0 | 1 | DF | INHALATION POWDER | |||||
| 126655652 | 12665565 | 3 | SS | SEREVENT DISKUS | SALMETEROL XINAFOATE | 1 | Y | 0 | INHALATION POWDER | ||||||||||
| 126655652 | 12665565 | 4 | SS | SEREVENT DISKUS | SALMETEROL XINAFOATE | 1 | Y | 0 | INHALATION POWDER | ||||||||||
| 126655652 | 12665565 | 5 | SS | SEREVENT DISKUS | SALMETEROL XINAFOATE | 1 | Y | 0 | INHALATION POWDER | ||||||||||
| 126655652 | 12665565 | 6 | SS | SEREVENT DISKUS | SALMETEROL XINAFOATE | 1 | Y | 0 | INHALATION POWDER | ||||||||||
| 126655652 | 12665565 | 7 | C | Albuterol Nebuliser solution | ALBUTEROL SULFATE | 1 | U | 0 | NEBULISER SOLUTION | ||||||||||
| 126655652 | 12665565 | 8 | C | ASMANEX | MOMETASONE FUROATE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126655652 | 12665565 | 1 | Product used for unknown indication |
| 126655652 | 12665565 | 2 | Bronchospasm |
| 126655652 | 12665565 | 3 | Asthma exercise induced |
| 126655652 | 12665565 | 4 | Bronchial hyperreactivity |
| 126655652 | 12665565 | 5 | Upper respiratory tract infection |
| 126655652 | 12665565 | 6 | Mycotic allergy |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126655652 | 12665565 | Adverse event | |
| 126655652 | 12665565 | Asthma | |
| 126655652 | 12665565 | Bronchospasm | |
| 126655652 | 12665565 | Chest discomfort | |
| 126655652 | 12665565 | Cough | |
| 126655652 | 12665565 | Dyspnoea | |
| 126655652 | 12665565 | Fatigue | |
| 126655652 | 12665565 | Respiratory disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126655652 | 12665565 | 2 | 201607 | 20160720 | 0 |